These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10622562)

  • 21. Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon.
    Herrmann E; Lee JH; Marinos G; Modi M; Zeuzem S
    Hepatology; 2003 Jun; 37(6):1351-8. PubMed ID: 12774014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C viral dynamics.
    Layden TJ; Lam NP; Wiley TE
    Clin Liver Dis; 1999 Nov; 3(4):793-810. PubMed ID: 11291251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin.
    Bekkering FC; Brouwer JT; Hansen BE; Schalm SW
    J Hepatol; 2001 Mar; 34(3):435-40. PubMed ID: 11322206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of treatment outcome in chronic hepatitis C patients based on early viral dynamics during high-dose induction interferon and ribavirin therapy.
    Kim TH; Kim KA; Lim YS; Gwak GY; Yoon JH; Kang GH; Lee HS
    Intervirology; 2005; 48(4):230-8. PubMed ID: 15920347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group.
    Bell H; Hellum K; Harthug S; Myrvang B; Ritland S; Maeland A; von der Lippe B; Bjøro K; Skaug K; Gutigard BG; Raknerud N; Simmonds P
    Scand J Gastroenterol; 1999 Feb; 34(2):194-8. PubMed ID: 10192200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus RNA level changes in sera during different regimens of treatment in patients with chronic hepatitis C.
    Mazur W; Gonciarz M; Mazurek U; Jurzak M; Wilczok T; Gonciarz Z
    Med Sci Monit; 2003 Aug; 9 Suppl 3():39-43. PubMed ID: 15156611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.
    Neumann AU; Lam NP; Dahari H; Gretch DR; Wiley TE; Layden TJ; Perelson AS
    Science; 1998 Oct; 282(5386):103-7. PubMed ID: 9756471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients.
    Sherman KE; Shire NJ; Rouster SD; Peters MG; James Koziel M; Chung RT; Horn PS
    Gastroenterology; 2005 Feb; 128(2):313-27. PubMed ID: 15685543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy.
    Terrault NA; Pawlotsky JM; McHutchison J; Anderson F; Krajden M; Gordon S; Zitron I; Perrillo R; Gish R; Holodniy M; Friesenhahn M
    J Viral Hepat; 2005 Sep; 12(5):465-72. PubMed ID: 16108760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of hepatitis C viremia following interferon-alpha administration.
    Yasui K; Okanoue T; Murakami Y; Itoh Y; Minami M; Sakamoto S; Sakamoto M; Nishioji K
    J Infect Dis; 1998 Jun; 177(6):1475-9. PubMed ID: 9607822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.
    Tsubota A; Arase Y; Someya T; Suzuki Y; Suzuki F; Saitoh S; Ikeda K; Akuta N; Hosaka T; Kobayashi M; Kumada H
    J Med Virol; 2005 Jan; 75(1):27-34. PubMed ID: 15543591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of pegylated interferon alpha-2a and ribavirin treatment in chronic hepatitis C patients depends on various baseline parameters and early viral kinetics].
    Husa P; Slesinger P; Stroblová H; Svobodník A; Husová L
    Klin Mikrobiol Infekc Lek; 2008 Apr; 14(2):67-73. PubMed ID: 18756436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a.
    Zeuzem S; Herrmann E; Lee JH; Fricke J; Neumann AU; Modi M; Colucci G; Roth WK
    Gastroenterology; 2001 May; 120(6):1438-47. PubMed ID: 11313314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C.
    Di Bisceglie AM; Ghalib RH; Hamzeh FM; Rustgi VK
    J Viral Hepat; 2007 Oct; 14(10):721-9. PubMed ID: 17875007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapy.
    Medeiros-Filho JE; de Carvalho Mello IM; Pinho JR; Neumann AU; de Mello Malta F; da Silva LC; Carrilho FJ
    World J Gastroenterol; 2006 Dec; 12(45):7271-7. PubMed ID: 17143940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy.
    Myers RP; Benhamou Y; Bochet M; Thibault V; Mehri D; Poynard T
    AIDS; 2004 Jan; 18(1):75-9. PubMed ID: 15090832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.
    Boulestin A; Kamar N; Sandres-Sauné K; Legrand-Abravanel F; Alric L; Vinel JP; Rostaing L; Izopet J
    J Med Virol; 2006 Mar; 78(3):365-71. PubMed ID: 16419107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial.
    Yu ML; Dai CY; Huang JF; Chiu CF; Yang YH; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Chuang WL
    Hepatology; 2008 Jun; 47(6):1884-93. PubMed ID: 18508296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.